Cargando…

Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database

Background. Treatment and management strategies for asthma in children are generally consistent internationally, but prescription of antiasthma drugs differs among countries. The objective of this study was to examine the prescribing patterns of antiasthma drugs, particularly controller medications,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Shota, Tokumasu, Hironobu, Sato, Akira, Iwasaku, Masahiro, Kawakami, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784626/
https://www.ncbi.nlm.nih.gov/pubmed/27335952
http://dx.doi.org/10.1177/2333794X15577790
_version_ 1782420296259600384
author Hamada, Shota
Tokumasu, Hironobu
Sato, Akira
Iwasaku, Masahiro
Kawakami, Koji
author_facet Hamada, Shota
Tokumasu, Hironobu
Sato, Akira
Iwasaku, Masahiro
Kawakami, Koji
author_sort Hamada, Shota
collection PubMed
description Background. Treatment and management strategies for asthma in children are generally consistent internationally, but prescription of antiasthma drugs differs among countries. The objective of this study was to examine the prescribing patterns of antiasthma drugs, particularly controller medications, in children. Methods. A retrospective cohort study was performed in children with asthma using an administrative claims database in Japan. Results. A total of 1149 preschool-age and 3226 school-age children were identified. Leukotriene receptor antagonists were prescribed for about 80% of the children. Long-acting β-agonists were prescribed for 87.6% and 59.6% of preschool-age and school-age children, respectively, whereas prescriptions of inhaled corticosteroids had lower rates of 8.2% and 16.5%, respectively. In an examination of prescriptions at 1-month intervals, a relatively high number of children were prescribed bronchodilators without anti-inflammatory agents. Conclusion. Our findings suggest that asthma care for children in Japan can be improved through changes in drug prescriptions.
format Online
Article
Text
id pubmed-4784626
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-47846262016-06-22 Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database Hamada, Shota Tokumasu, Hironobu Sato, Akira Iwasaku, Masahiro Kawakami, Koji Glob Pediatr Health Original Article Background. Treatment and management strategies for asthma in children are generally consistent internationally, but prescription of antiasthma drugs differs among countries. The objective of this study was to examine the prescribing patterns of antiasthma drugs, particularly controller medications, in children. Methods. A retrospective cohort study was performed in children with asthma using an administrative claims database in Japan. Results. A total of 1149 preschool-age and 3226 school-age children were identified. Leukotriene receptor antagonists were prescribed for about 80% of the children. Long-acting β-agonists were prescribed for 87.6% and 59.6% of preschool-age and school-age children, respectively, whereas prescriptions of inhaled corticosteroids had lower rates of 8.2% and 16.5%, respectively. In an examination of prescriptions at 1-month intervals, a relatively high number of children were prescribed bronchodilators without anti-inflammatory agents. Conclusion. Our findings suggest that asthma care for children in Japan can be improved through changes in drug prescriptions. SAGE Publications 2015-04-02 /pmc/articles/PMC4784626/ /pubmed/27335952 http://dx.doi.org/10.1177/2333794X15577790 Text en © The Author(s) 2015 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).
spellingShingle Original Article
Hamada, Shota
Tokumasu, Hironobu
Sato, Akira
Iwasaku, Masahiro
Kawakami, Koji
Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
title Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
title_full Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
title_fullStr Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
title_full_unstemmed Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
title_short Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
title_sort asthma controller medications for children in japan: analysis of an administrative claims database
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784626/
https://www.ncbi.nlm.nih.gov/pubmed/27335952
http://dx.doi.org/10.1177/2333794X15577790
work_keys_str_mv AT hamadashota asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase
AT tokumasuhironobu asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase
AT satoakira asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase
AT iwasakumasahiro asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase
AT kawakamikoji asthmacontrollermedicationsforchildreninjapananalysisofanadministrativeclaimsdatabase